Please assess the completion status of the following clinical trial:

Trial Title: Managed Ventricular Pacing (MVP) Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Conventional indication for ICD therapy according to current evidence-based guidelines and in accordance with the corresponding United States Centers for Medicare and Medicaid Services National Coverage Determination for the use of ICDs.~* Prior myocardial infarction (MI) and an left ventricular ejection fraction (LVEF) of less than 30%~* Ischemic Dilated Cardiomyopathy (IDCM), New York Heart Association (NYHA) Class II or II heart failure, and LVEF less than or equal to 35%~* Non-Ischemic Dilated Cardiomyopathy (NIDCM) greater than 3 months, NYHA Class II or II heart failure, and LVEF less than or equal to 35%~* First ICD implant~* Successful implant with a study device with approved labeling~Exclusion Criteria:~* Failure to meet any of the inclusion criteria~* Class I pacing indication~* Chronic atrial fibrillation (AF) without any documented sinus mechanism for at least 6 months~* Inability or unwillingness to give informed consent~* Life expectancy less than 12 months or a heart transplant anticipated within 6 months~* Inability to successfully comply with study participation and follow up requirements~* Patient involved in another clinical trial that may confound the results of the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- VVI 40 pacing (Type: ACTIVE_COMPARATOR): Backup ventricular pacing (VVI) at 40 beats per minute
- MVP pacing (Type: ACTIVE_COMPARATOR): Managed ventricular pacing (MVP) at 60 beats per minute

Based on this trial design, predict the completion outcome and termination type (if applicable).